Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment-Reference-Cited by-同舟云学术

Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment

Published:2022-08 Issue:35 Volume:40 Page:5248-5262
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Folegatti Pedro M,Jenkin Daniel,Morris Susan,Gilbert Sarah,Kim Denny,Robertson James S.,Smith Emily R.,Martin Emalee,Gurwith Marc,Chen Robert T.

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Coalition for Epidemic Preparedness Innovations

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference109 articles.

1. The brighton collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI);Bonhoeffer;Vaccine,2002

2. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG);Chen;Vaccine,2015

3. Adenoviruses as vaccine vectors;Tatsis;Mol Ther,2004

4. Step study protocol team. An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study);Fitzgerald;J Infect Dis,2011

5. Merck V520–016 study group. safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults;Priddy;Clin Infect Dis,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress on the research and development of plague vaccines with a call to action;npj Vaccines;2024-09-07

2. Development of a novel adenovirus serotype 35 vector vaccine possessing an RGD peptide in the fiber knob and the E4 orf 4, 6, and 6/7 regions of adenovirus serotype 5;International Journal of Pharmaceutics;2024-09

3. The systemic capillary leak syndrome following COVID-19 vaccine;Human Vaccines & Immunotherapeutics;2024-08-22

4. Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors;Journal for ImmunoTherapy of Cancer;2024-08

5. Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions;Frontiers in Microbiology;2024-07-22